Elicio Therapeutics (ELTX) Return on Sales (2020 - 2023)
Elicio Therapeutics' (ELTX) quarterly Return on Sales came in at 0.49% in Q1 2023, down 40.0% YoY from 0.81% in Q1 2022, and down 191.29% on a QoQ basis from 0.17% in Q4 2022.
Elicio Therapeutics (ELTX) Return on Sales (2020 - 2023) Analysis & Trends
Elicio Therapeutics (ELTX) has 4 years of Return on Sales data on file, last reported at 0.49% in Q1 2023.
- Quarterly Return on Sales fell 40.0% year-over-year to 0.49% in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.49% (down 46.0% YoY) and the FY2022 annual result came in at 0.22%, down 20.0% from the prior year.
- Return on Sales declined to 0.49% in Q1 2023, from 0.17% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2021 to a low of 0.82% in Q2 2021.
- A 4-year average of 0.26% and a median of 0.2% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2021 — Return on Sales plunged 58 bps — and 2022, when it surged 71 bps.
- Tracing ELTX's Return on Sales over 4 years: stood at 0.28% in 2020, then soared by 102 bps to 0.01% in 2021, then tumbled by 3126 bps to 0.17% in 2022, then slumped by 191 bps to 0.49% in 2023.
- The last three Return on Sales figures came in at 0.49% (Q1 2023), 0.17% (Q4 2022), and 0.01% (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 0.00% |
| 10 | Elicio Therapeutics | 58.70 Mn | 35.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -0.49% |
| Dec 31, 2022 | -0.17% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.11% |
| Mar 31, 2022 | -0.09% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | -0.28% |
| Jun 30, 2021 | -0.82% |
| Mar 31, 2021 | -0.54% |
| Dec 31, 2020 | -0.28% |
| Sep 30, 2020 | -0.14% |
| Jun 30, 2020 | -0.24% |